Laura L. Johnson

Insider Reports History

Entity
Individual
Location
C/O La Jolla Pharmaceutical Company, La Jolla Village Drive, Suite 1070, San Diego, CA
Signature
/s/ Laura L. Johnson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura L. Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kintara Therapeutics, Inc. Director Options (Right to Buy) 8.5K Aug 30, 2023 Direct
LA JOLLA PHARMACEUTICAL CO Director Common Stock 0 $6.23 Aug 22, 2022 Direct
LA JOLLA PHARMACEUTICAL CO Director Stock Option (Right to Buy) 0 Aug 22, 2022 Direct

Insider Reports Filed by Laura L. Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KTRA Kintara Therapeutics, Inc. Aug 30, 2023 1 $0 4 Sep 1, 2023 Director
LJPC LA JOLLA PHARMACEUTICAL CO Aug 22, 2022 11 -$3.12K 4 Aug 24, 2022 Director
KTRA Kintara Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 5, 2022 Director
LJPC LA JOLLA PHARMACEUTICAL CO Jan 12, 2022 1 $0 4 Jan 14, 2022 Director
KTRA Kintara Therapeutics, Inc. Nov 22, 2021 1 $2.23K 4 Nov 24, 2021 Director
KTRA Kintara Therapeutics, Inc. Sep 22, 2021 1 $0 4 Sep 22, 2021 Director